Furthermore, the properties of NPC CSCs were studied by treating NPC cells with rapamycin to determine whether inhibition of the mTOR signaling pathway would reduce the number of CD44-positive cells and depress cancer cell proliferation. The gene discussed is CD44; the disease is nasopharyngeal carcinoma.